Abstract
Recombinant adeno-associated virus (rAAV)-mediated gene therapy is a fast-evolving field in the biotechnology industry. One of the major challenges in developing a purification process for AAV gene therapy is establishing an effective yet scalable method to remove empty capsids, or viral vectors lacking the therapeutic gene, from full capsids-viral product containing the therapeutic sequence. Several analytical methods that can quantify the empty-to-full capsid ratio have been reported in the literature. However, as samples can vary widely in viral titer, buffer matrix, and the relative level of empty capsids, understanding the specifications and limitations of different analytical methods is critical to providing appropriate support to facilitate process development. In this study, we developed a novel anion-exchange high-performance liquid chromatography assay to determine the empty-to-full capsid ratio of rAAV samples. The newly developed method demonstrated good comparability with both the transmission electron microscopy and analytical ultracentrifugation methods used in empty-to-full capsid ratio quantification, while providing much higher assay throughput and reducing the minimum sample concentration requirement to 2.7E1...Continue Reading
References
Aug 24, 1999·Gene Therapy·D GrimmJ Kleinschmidt
Feb 29, 2000·Biophysical Journal·P Schuck
Mar 30, 2000·The Journal of Gene Medicine·R O Snyder
Nov 10, 2001·Annual Review of Genomics and Human Genetics·A Pfeifer, I M Verma
Nov 20, 2001·EMBO Reports·S KronenbergB Böttcher
Feb 8, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jürg M SommerJ Fraser Wright
Sep 24, 2004·Journal of Virological Methods·Andrew M DavidoffAmit C Nathwani
Jan 5, 2005·Bosnian Journal of Basic Medical Sciences·Branko NikolinMiroslav Sober
Jun 25, 2005·Current Gene Therapy·Jennifer TimpeJames P Trempe
Jun 25, 2005·Current Gene Therapy·Anne K Zaiss, Daniel A Muruve
Feb 14, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Masashi UrabeKeiya Ozawa
Jan 2, 2007·Journal of Virological Methods·Guang QuJ Fraser Wright
Apr 24, 2009·Journal of Chromatography. a·Dragana C RadenovićGovert W Somsen
Nov 12, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Zhijian WuPeter Colosi
Nov 16, 2010·Applied Spectroscopy·Matthew S Heywood, Paul B Farnsworth
Mar 18, 2011·Human Gene Therapy·James A AllayJohn T Gray
Mar 21, 2012·Human Gene Therapy Methods·Martin LockJames M Wilson
Jan 5, 2014·Molecular Therapy : the Journal of the American Society of Gene Therapy·J Fraser Wright
Sep 29, 2015·Human Gene Therapy Methods·Brenda BurnhamCatherine R O'Riordan
Jun 17, 2016·Analytical Chemistry·Elizabeth E PiersonMartin F Jarrold
Aug 25, 2017·Human Gene Therapy·Céline VandammeFederico Mingozzi
Sep 26, 2017·Frontiers in Neuroscience·Livia S CarvalhoLuk H Vandenberghe
Citations
Oct 2, 2020·Biotechnology Journal·Ryan DickersonMeisam Bakhshayeshi
Jan 23, 2021·Pharmaceutics·Pete GagnonAles Strancar
Mar 20, 2021·Molecular Therapy. Methods & Clinical Development·Andreas L GimpelRichard D Braatz
Apr 27, 2021·Molecular Therapy. Methods & Clinical Development·Pranav R H JoshiAmine Kamen
May 26, 2021·Journal of Chromatography. a·Pete GagnonAles Štrancar
May 18, 2021·Molecular Therapy. Methods & Clinical Development·Santoshkumar L KhatwaniZhu Pirot
Apr 17, 2021·Human Gene Therapy·Pranav R H JoshiAmine Kamen
Jun 30, 2021·Journal of Pharmaceutical Sciences·Takahiro MarunoSusumu Uchiyama
Jul 18, 2021·Current Opinion in Biotechnology·Erica A Green, Kelvin H Lee
Jul 27, 2021·Biotechnology and Bioengineering·Andrew D Tustian, Hanne Bak
Aug 28, 2021·Human Gene Therapy·He MengClaire Davies
Nov 19, 2021·Analytical Chemistry·Marc B TarabanYihua Bruce Yu
Nov 26, 2021·Electrophoresis·Andrei HutanuMaria A Schwarz